Stem cell bioprocess engineering towards cGMP production and clinical applications

Cytotechnology

Volumn 66, Issue 5, 2014, Pages 709-722

  Sart, Sébastien ^a   Schneider, Yves Jacques ^b   Li, Yan ^a   Agathos, Spiros N ^b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Bioprocess engineering; Bioreactor; Differentiation; Safety; Stem cells

Indexed keywords

EID: 84921489555     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-013-9687-7     Document Type: Review

References (115)

1. Abbasalizadeh S, Baharvand H (2013) Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies. Biotechnol Adv 31:1600–1623
2. Abranches E, Bekman E, Henrique D, Cabral JMS (2007) Expansion of mouse embryonic stem cells on microcarriers. Biotechnol Bioeng 96:1211–1221
3. Alfred R, Gareau T, Krawetz R, Rancourt D, Kallos MS (2010) Serum-free scaled up expansion and differentiation of murine embryonic stem cells to osteoblasts in suspension bioreactors. Biotechnol Bioeng 106:829–840
4. Alper J (2009) Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol 27:213–214
5. Augello A, Kurth TB, De Bari C (2010) Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 20:121–133
6. Baker DE, Harrison NJ, Maltby E, Smith K, Moore HD, Shaw PJ, Heath PR, Holden H, Andrews PW (2007) Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 25:207–215
7. Bardy J, Chen AK, Lim YM, Wu S, Wei S, Weiping H, Chan K, Reuveny S, Oh SK (2013) Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Eng Part C Methods 19:166–180
8. Bhang SH, Cho SW, La WG, Lee TJ, Yang HS, Sun AY, Baek SH, Rhie JW, Kim BS (2011) Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials 32:2734–2747
9. Bieberich E, MacKinnon S, Silva J, Noggle S, Condie BG (2003) Regulation of cell death in mitotic neural progenitor cells by asymmetric distribution of prostate apoptosis response 4 (PAR-4) and simultaneous elevation of endogenous ceramide. J Cell Biol 162:469–479
10. Blum B, Benvenisty N (2009) The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 8:3822–3830
11. Bongso A, Fong C-Y, Gauthaman K (2008) Taking stem cells to the clinic: major challenges. J Cell Biochem 105:1352–1360
12. Bratt-Leal AM, Carpenedo RL, McDevitt TC (2009) Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog 25:43–51
13. Bratt-Leal AM, Carpenedo RL, Ungrin MD, Zandstra PW, McDevitt TC (2011) Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation. Biomaterials 32:48–56
14. Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076–1084
15. Carpenter MK, Frey-Vasconcells J, Rao MS (2009) Developing safe therapies from human pluripotent stem cells. Nat Biotechnol 27:606–613
16. Chen X, Chen A, Woo TL, Choo AB, Reuveny S, Oh SK (2010) Investigations into the metabolism of two-dimensional colony and suspended microcarrier cultures of human embryonic stem cells in serum-free media. Stem Cells Dev 19:1781–1792
17. Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE, Diol NR, Propson NE, Wagner R, Lee GO, Antosiewicz-Bourget J, Teng JM, Thomson JA (2011) Chemically defined conditions for human iPSC derivation and culture. Nat Methods 8:424–429
18. Cimetta E, Sirabella D, Yeager K, Davidson K, Simon J, Moon RT, Vunjak-Novakovic G (2013) Microfluidic bioreactor for dynamic regulation of early mesodermal commitment in human pluripotent stem cells. Lab Chip 13:355–364
19. Cuiffo BG, Karnoub AE (2012) Mesenchymal stem cells in tumor development: emerging roles and concepts. Cell Adh Migr 6:220–230
20. Diogo MM, da Silva CL, Cabral JM (2012) Separation technologies for stem cell bioprocessing. Biotech Bioeng 109:2699–2709
21. Dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JM (2010) Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol 223:27–35
22. Dressel R (2011) Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells. Semin Immunopathol 33:573–591
23. FDA, Guidance for FDA reviewers and sponsors (2008) Content and review of chemistry, manufacturing, and control (CMC) information for human gene therapy investigational new drug applications (INDs). http://www.fda.gov
24. Ferreira L, Squier T, Park H, Choe H, Kohane DS, Langer R (2008) Human embryoid bodies containing nano- and microparticulate delivery vehicles. Adv Mater 20:2285–2291
25. Fluri DA, Tonge PD, Song H, Baptista RP, Shakiba N, Shukla S, Clarke G, Nagy A, Zandstra PW (2012) Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat Methods 9:509–516
26. Fong C-Y, Gauthaman K, Bongso A (2010) Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem 111:769–781
27. Fridley KM, Fernandez I, Li MT, Kettlewell RB, Roy K (2010) Unique differentiation profile of mouse embryonic stem cells in rotary and stirred tank bioreactors. Tissue Eng Part A 16:3285–3298
28. Frith JE, Thomson B, Genever PG (2010) Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 16:735–749
29. Gao L, McBeath R, Chen CS (2010) Stem cell shape regulates a chondrogenic versus myogenic fate through Rac1 and N-cadherin. Stem Cells 28:564–572
30. Gareau T, Lara GG, Shepherd RD, Krawetz R, Rancourt DE, Rinker KD, Kallos MS (2012) Shear stress influences the pluripotency of murine embryonic stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med doi:10.1002/term.1518
31. Godara P, McFarland CD, Nordon RE (2008) Design of bioreactors for mesenchymal stem cell tissue engineering. J Chem Technol Biotechnol 83:408–420
32. Goh TKP, Zhang ZY, Chen AKL, Reuveny S, Choolani M, Chan JKY, Oh SKW (2013) Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells. Biores Open Access 2:84–97
33. Gonçalves A, Costa P, Rodrigues MT, Dias IR, Reis RL, Gomes ME (2011) Effect of flow perfusion conditions in the chondrogenic differentiation of bone marrow stromal cells cultured onto starch based biodegradable scaffolds. Acta Biomater 7:1644–1652
34. Griffin MD, Ritter T, Mahon BP (2010) Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 21:1641–1655
35. Grinnemo KH, Sylvén C, Hovatta O, Dellgren G, Corbascio M (2008) Immunogenicity of human embryonic stem cells. Cell Tissue Res 331:67–78
36. Hara K, Yasuhara T, Maki M, Matsukawa N, Masuda T, Yu SJ, Ali M, Yu G, Xu L, Kim SU, Hess DC, Borlongan CV (2008) Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol 85:318–334
37. Hedlund E, Pruszak J, Lardaro T, Ludwig W, Viñuela A, Kim KS, Isacson O (2008) Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson’s disease. Stem Cells 26:1526–1536
38. Heng TS, Dudakov JA, Khong DM, Chidgey AP, Boyd RL (2009) Stem cells—meet immunity. J Mol Med 87:1061–1069
39. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932–8937
40. Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341:651–654. doi:10.1126/science.1239278
41. Huang CY, Hagar KL, Frost LE, Sun Y, Cheung HS (2004) Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells 22:313–323
42. Hwang D-Y, Kim D-S, Kim D-W (2010) Human ES and iPS cells as cell sources for the treatment of Parkinson’s disease: current state and problems. J Cell Biochem 109:292–301
43. Kabiri M, Kul B, Lott WB, Futrega K, Ghanavi P, Upton Z, Doran MR (2012) 3-D mesenchymal stem/stromal cell osteogenesis and autocrine signalling. Biochem Biophys Res Commun 419:142–147
44. Kaiser SC, Jossen V, Schirmaier C, Eibl D, Brill S, van den Bos C, Eibl R (2013) Investigations of fluid flow and cell proliferation of mesenchymal adipose-derived stem cells in small-scale, stirred, single-use bioreactors. Chem Ing Tech 85:95–102
45. King JA, Miller WM (2007) Bioreactor development for stem cell expansion and controlled differentiation. Curr Opin Chem Biol 11:394–398
46. Knoepfler PS (2009) Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27:1050–1056
47. Kreke MR, Sharp LA, Lee YW, Goldstein AS (2008) Effect of intermittent shear stress on mechanotransductive signaling and osteoblastic differentiation of bone marrow stromal cells. Tissue Eng Part A 14:529–537
48. Lazennec G, Jorgensen C (2008) Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 26:1387–1394
49. Lecina M, Ting S, Choo A, Reuveny S, Oh S (2010) Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods 16:1609–1619
50. Lennon DP, Haynesworth SE, Young RG, Dennis JE, Caplan AI (1995) A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 219:211–222
51. Leung HW, Chen A, Choo AB, Reuveny S, Oh SK (2010) Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng Part C Methods 17:165–172
52. Li Y, Kniss DA, Lasky LC, Yang ST (2003) Culturing and differentiation of murine embryonic stem cells in a three-dimensional fibrous matrix. Cytotechnology 41:23–35
53. Li D, Tang T, Lu J, Dai K (2009) Effects of flow shear stress and mass transport on the construction of a large-scale tissue-engineered bone in a perfusion bioreactor. Tissue Eng Part A 15:2773–2783
54. Li Y, Gautam A, Yang J, Qiu L, Melkoumian Z, Weber J, Telukuntla L, Srivastava R, Whiteley EM, Brandenberger R (2013) Differentiation of oligodendrocyte progenitor cell differentiation from human embryonic stem cells on vitronectin-derived synthetic peptide acrylate surface. Stem Cells Dev 22:1497–1505
55. Liu L, Yuan W, Wang J (2010) Mechanisms for osteogenic differentiation of human mesenchymal stem cells induced by fluid shear stress. Biomech Model Mechanobiol 9:659–670
56. Liu N, Zang R, Yang S-T, Li Y (2013) Stem cell engineering in bioreactors for large scale bioprocessing. Eng Life Sci. doi:10.1002/elsc.201300013
57. Lo T, Ho JH, Yang M-H, Lee OK (2011) Glucose reduction prevents replicative senescence and increases mitochondrial respiration in human mesenchymal stem cells. Cell Transpl 20:813–825
58. Lovett M, Rockwood D, Baryshyan A, Kaplan DL (2010) Simple modular bioreactors for tissue engineering: a system for characterization of oxygen gradients, human mesenchymal stem cell differentiation, and prevascularization. Tissue Eng Part C Methods 16:1565–1573
59. Lutolf MP, Blau HM (2009) Artificial stem cell niches. Adv Mater 21:3255–3268
60. Mandenius CF, Steel D, Noor F, Meyer T, Heinzle E, Asp J, Arain S, Kraushaar U, Bremer S, Class R, Sartipy P (2011) Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review. J Appl Toxicol 31:191–205
61. Martín PG, Martinez AR, Lara VG, Naveros BC (2014) Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research. Clin Exp Med 14:25–33
62. Massard C, Deutsch E, Soria J-C (2006) Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol 17:1620–1624
63. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS (2004) Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6:483–495
64. Meyers VE, Zayzafoon M, Douglas JT, McDonald JM (2005) RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. J Bone Miner Res 20:1858–1866
65. Niebruegge S, Bauwens CL, Peerani R, Thavandiran N, Masse S, Sevaptisidis E, Nanthakumar K, Woodhouse K, Husain M, Kumacheva E, Zandstra PW (2009) Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng 102:493–507
66. Oh S, Choo ABH (2006) Human embryonic stem cell technology: large scale cell amplification and differentiation. Cytotechnology 50:181–190
67. Okamoto OK, Carvalho AC, Marti LC, Vêncio RZ, Moreira-Filho CA (2007) Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer. Cancer Cell Int 7:11
68. Outten JT, Cheng X, Gadue P, French DL, Diamond SL (2011) A high-throughput multiplexed screening assay for optimizing serum-free differentiation protocols of human embryonic stem cells. Stem Cell Res 6:129–142
69. Peerani R, Onishi K, Mahdavi A, Kumacheva E, Zandstra PW (2009) Manipulation of signaling thresholds in “engineered stem cell niches” identifies design criteria for pluripotent stem cell screens. PLoS ONE 4:e6438
70. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
71. Przybyla LM, Voldman J (2012) Attenuation of extrinsic signaling reveals the importance of matrix remodeling on maintenance of embryonic stem cell self-renewal. Proc Natl Acad Sci USA 109:835–840
72. Ratcliffe E, Thomas RJ, Williams DJ (2011) Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine. Br Med Bull 100:137–155
73. Ratcliffe E, Hourd P, Guijarro-Leach J, Rayment E, Williams DJ, Thomas RJ (2013) Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture. Regen Med 8:39–48
74. Rodriguez R, Rubio R, Menendez P (2012) Modeling sarcomagenesis using multipotent mesenchymal stem cells. Cell Res 22:62–77
75. Sargent CY, Berguig GY, McDevitt TC (2009) Cardiomyogenic differentiation of embryoid bodies is promoted by rotary orbital suspension culture. Tissue Eng Part A 15:331–342
76. Sart S, Schneider Y-J, Agathos SN (2010) Influence of culture parameters on ear mesenchymal stem cells expanded on microcarriers. J Biotechnol 150:149–160
77. Sart S, Errachid A, Schneider Y-J, Agathos SN (2013a) Modulation of mesenchymal stem cell actin organization on conventional microcarriers for proliferation and differentiation in stirred bioreactors. J Tissue Eng Regen Med 7:537–551
78. Sart S, Ma T, Li Y (2013b) Cryopreservation of pluripotent stem cell aggregates in defined protein-free formulation. Biotechnol Prog 29:143–153
79. Sart S, Agathos SN, Li Y (2013c) Engineering stem cell fate with biochemical and biomechanical properties of microcarriers. Biotechnol Prog 29:1354–1366
80. Sart S, Tsai AC, Li Y, Ma T (2013d) Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. Tissue Eng Part B. doi:10.1089/ten.teb.2013.0537
81. Scadden DT (2006) The stem-cell niche as an entity of action. Nature 441:1075–1079
82. Schop D, van Dijkhuizen-Radersma R, Borgart E, Janssen FW, Rozemuller H, Prins HJ, de Bruijn JD (2010) Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism. J Tissue Eng Regen Med 4:131–140
83. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379:713–720
84. Sensebe L, Bourin P, Tarte K (2011) Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 22:19–26
85. Serra M, Brito C, Sousa MF, Jensen J, Tostões R, Clemente J, Strehl R, Hyllner J, Carrondo MJ, Alves PM (2010) Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol 148:208–215
86. Serra M, Brito C, Correia C, Alves PM (2012) Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol 30:350–359
87. Sharma S, Raju R, Sui S, Hu WS (2011) Stem cell culture engineering—process scale up and beyond. Biotechnol J 6:1317–1329
88. Shay JW, Wright WE (2010) Telomeres and telomerase in normal and cancer stem cells. FEBS Lett 584:3819–3825
89. Sheyn D, Pelled G, Netanely D, Domany E, Gazit D (2010) The effect of simulated microgravity on human mesenchymal stem cells cultured in an osteogenic differentiation system: a bioinformatics study. Tissue Eng Part A 16:3403–3412
90. Shih Y-RV, Tseng K-F, Lai H-Y, Lin C-H, Lee OK (2011) Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res 26:730–738
91. Simaria AS, Hassan S, Varadaraju H, Rowley J, Warren K, Vanek P, Farid SS (2014) Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies. Biotechnol Bioeng 111:69–83. doi:10.1002/bit.25008
92. Singh H, Mok P, Balakrishnan T, Rahmat SNB, Zweigerdt R (2010) Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res 4:165–179
93. Spangrude GJ, Muller-Sieburg CE, Heimfeld S, Weissman IL (1988) Two rare populations of mouse Thy-1lo bone marrow cells repopulate the thymus. J Exp Med 167:1671–1683
94. Stadtfeld M, Hochedlinger K (2010) Induced pluripotency: history, mechanisms, and applications. Genes Dev 24:2239–2263
95. Stenberg J, Elovsson M, Strehl R, Kilmare E, Hyllner J, Lindahl A (2011) Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells. Cytotechnology 63:227–237
96. Storm MP, Orchard CB, Bone HK, Chaudhuri JB, Welham MJ (2010) Three-dimensional culture systems for the expansion of pluripotent embryonic stem cells. Biotechnol Bioeng 107:683–695
97. Sun Y, Chen CS, Fu J (2012) Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment. Annu Rev Biophys 41:519–542
98. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
99. Takehara M, Hoshino T, Namba T, Yamakawa N, Mizushima T (2011) Acetaminophen-induced differentiation of human breast cancer stem cells and inhibition of tumor xenograft growth in mice. Biochem Pharmacol 81:1124–1135
100. Tan HL, Fong WJ, Lee EH, Yap M, Choo A (2009) mAb 84, a cytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis. Stem Cells 27:1792–1801
101. Taylor CJ, Bolton EM, Bradley JA (2011) Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R Soc Lond B Biol Sci 366:2312–2322
102. Terstegge S, Laufenberg I, Pochert J, Schenk S, Itskovitz-Eldor J, Endl E, Brüstle O (2007) Automated maintenance of embryonic stem cell cultures. Biotechnol Bioeng 96:195–201
103. Thomas R, Ratcliffe E (2012) Automated adherent human cell culture (mesenchymal stem cells). Methods Mol Biol 806:393–406
104. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
105. Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17:R48–R53
106. Wagner J, Kean T, Young R, Dennis JE, Caplan AI (2009) Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20:531–536
107. Wang Y, Zhang Y, Zhang S, Peng G, Liu T, Li Y, Xiang D, Wassler MJ, Shelat HS, Geng Y (2012) Rotating microgravity-bioreactor cultivation enhances the hepatic differentiation of mouse embryonic stem cells on biodegradable polymer scaffolds. Tissue Eng Part A 18:2376–2385
108. Watt FM, Hogan BL (2000) Out of Eden: stem cells and their niches. Science 287:1427–1430
109. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP (2013) A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 143:1590–1598
110. Wolfe RP, Ahsan T (2013) Shear stress during early embryonic stem cell differentiation promotes hematopoietic and endothelial phenotypes. Biotechnol Bioeng 110:1231–1242
111. Wolfe RP, Leleux J, Nerem RM, Ahsan T (2012) Effects of shear stress on germ lineage specification of embryonic stem cells. Integr Biol (Camb) 4:1263–1273
112. Yirme G, Amit M, Laevsky I, Osenberg S, Itskovitz-Eldor J (2008) Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev 17:1227–1241
113. Zhang ZY, Teoh SH, Teo EY, Khoon Chong MS, Shin CW, Tien FT, Choolani MA, Chan JK (2010) A comparison of bioreactors for culture of fetal mesenchymal stem cells for bone tissue engineering. Biomaterials 31:8684–8695
114. Zhao T, Zhang Z-N, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474:212–215
115. Zoldan J, Karagiannis ED, Lee CY, Anderson DG, Langer R, Levenberg S (2011) The influence of scaffold elasticity on germ layer specification of human embryonic stem cells. Biomaterials 32:9612–9621